Zaja Ivan, Bai Xiaowen, Liu Yanan, Kikuchi Chika, Dosenovic Svjetlana, Yan Yasheng, Canfield Scott G, Bosnjak Zeljko J
Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, WI 53226, United States.
Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, WI 53226, United States.
Biochem Biophys Res Commun. 2014 Oct 31;453(4):710-21. doi: 10.1016/j.bbrc.2014.09.144. Epub 2014 Oct 14.
Myocardial ischemia-reperfusion (I/R) injury is one of the leading causes of death and disability worldwide. Mitochondrial fission has been shown to be involved in cardiomyocyte death. However, molecular machinery involved in mitochondrial fission during I/R injury has not yet been completely understood. In this study we aimed to investigate molecular mechanisms of controlling activation of dynamin-related protein 1 (Drp1, a key protein in mitochondrial fission) during anoxia-reoxygenation (A/R) injury of HL1 cardiomyocytes. A/R injury induced cardiomyocyte death accompanied by the increases of mitochondrial fission, reactive oxygen species (ROS) production and activated Drp1 (pSer616 Drp1), and decrease of inactivated Drp1 (pSer637 Drp1) while mitochondrial fusion protein levels were not significantly changed. Blocking Drp1 activity with mitochondrial division inhibitor mdivi1 attenuated cell death, mitochondrial fission, and Drp1 activation after A/R. Trolox, a ROS scavenger, decreased pSer616 Drp1 level and mitochondrial fission after A/R. Immunoprecipitation assay further indicates that cyclin dependent kinase 1 (Cdk1) and protein kinase C isoform delta (PKCδ) bind Drp1, thus increasing mitochondrial fission. Inhibiting Cdk1 and PKCδ attenuated the increases in pSer616 Drp1, mitochondrial fission, and cardiomyocyte death. FK506, a calcineurin inhibitor, blocked the decrease in expression of inactivated pSer637 Drp1 and mitochondrial fission. Our findings reveal the following novel molecular mechanisms controlling mitochondrial fission during A/R injury of cardiomyocytes: (1) ROS are upstream initiators of mitochondrial fission; and (2) the increased mitochondrial fission is resulted from both increased activation and decreased inactivation of Drp1 through Cdk1, PKCδ, and calcineurin-mediated pathways, respectively.
心肌缺血再灌注(I/R)损伤是全球范围内导致死亡和残疾的主要原因之一。线粒体分裂已被证明与心肌细胞死亡有关。然而,I/R损伤期间参与线粒体分裂的分子机制尚未完全明确。在本研究中,我们旨在探讨HL1心肌细胞缺氧复氧(A/R)损伤过程中,调控动力相关蛋白1(Drp1,线粒体分裂中的关键蛋白)激活的分子机制。A/R损伤诱导心肌细胞死亡,同时伴随着线粒体分裂增加、活性氧(ROS)生成以及激活的Drp1(pSer616 Drp1)增加,而失活的Drp1(pSer637 Drp1)减少,同时线粒体融合蛋白水平无显著变化。用线粒体分裂抑制剂mdivi1阻断Drp1活性可减轻A/R后的细胞死亡、线粒体分裂和Drp1激活。ROS清除剂Trolox可降低A/R后pSer616 Drp1水平和线粒体分裂。免疫沉淀分析进一步表明,细胞周期蛋白依赖性激酶1(Cdk1)和蛋白激酶Cδ亚型(PKCδ)与Drp1结合,从而增加线粒体分裂。抑制Cdk1和PKCδ可减轻pSer616 Drp1、线粒体分裂和心肌细胞死亡的增加。钙调神经磷酸酶抑制剂FK506可阻断失活的pSer637 Drp1表达降低和线粒体分裂。我们的研究结果揭示了心肌细胞A/R损伤期间控制线粒体分裂的以下新分子机制:(1)ROS是线粒体分裂的上游启动因子;(2)线粒体分裂增加分别是通过Cdk1、PKCδ和钙调神经磷酸酶介导的途径,使Drp1的激活增加和失活减少所致。